img

Global Human Hyperimmune Globulins Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Hyperimmune Globulins Market Insights, Forecast to 2034

Global Human Hyperimmune Globulins market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Hyperimmune Globulins industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Human Hyperimmune Globulins key manufacturers include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG and Hualan Bio, etc. CSL Behring, Grifols, Biotest are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Human Hyperimmune Globulins were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Human Hyperimmune Globulins market and estimated to attract more attentions from industry insiders and investors.
Human Hyperimmune Globulins can be divided into Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins and Others, etc. Hepatitis B Immunoglobulins is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Human Hyperimmune Globulins is widely used in various fields, such as Government Institutions, Private Sector and Others,, etc. Government Institutions provides greatest supports to the Human Hyperimmune Globulins industry development. In 2022, global % sales of Human Hyperimmune Globulins went into Government Institutions filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Human Hyperimmune Globulins market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Hyperimmune Globulins market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics
Segment by Type
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

Segment by Application


Government Institutions
Private Sector
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Hyperimmune Globulins plant distribution, commercial date of Human Hyperimmune Globulins, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Hyperimmune Globulins introduction, etc. Human Hyperimmune Globulins Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Human Hyperimmune Globulins
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Hyperimmune Globulins Product Introduction
1.2 Market by Type
1.2.1 Global Human Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market by Application
1.3.1 Global Human Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Hyperimmune Globulins Sales Estimates and Forecasts 2018-2029
2.2 Global Human Hyperimmune Globulins Revenue by Region
2.2.1 Global Human Hyperimmune Globulins Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Hyperimmune Globulins Revenue by Region (2018-2024)
2.2.3 Global Human Hyperimmune Globulins Revenue by Region (2024-2029)
2.2.4 Global Human Hyperimmune Globulins Revenue Market Share by Region (2018-2029)
2.3 Global Human Hyperimmune Globulins Sales Estimates and Forecasts 2018-2029
2.4 Global Human Hyperimmune Globulins Sales by Region
2.4.1 Global Human Hyperimmune Globulins Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Hyperimmune Globulins Sales by Region (2018-2024)
2.4.3 Global Human Hyperimmune Globulins Sales by Region (2024-2029)
2.4.4 Global Human Hyperimmune Globulins Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Hyperimmune Globulins Sales by Manufacturers
3.1.1 Global Human Hyperimmune Globulins Sales by Manufacturers (2018-2024)
3.1.2 Global Human Hyperimmune Globulins Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Hyperimmune Globulins in 2022
3.2 Global Human Hyperimmune Globulins Revenue by Manufacturers
3.2.1 Global Human Hyperimmune Globulins Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Hyperimmune Globulins Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Hyperimmune Globulins Revenue in 2022
3.3 Global Key Players of Human Hyperimmune Globulins, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Hyperimmune Globulins Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Hyperimmune Globulins, Product Offered and Application
3.8 Global Key Manufacturers of Human Hyperimmune Globulins, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Hyperimmune Globulins Sales by Type
4.1.1 Global Human Hyperimmune Globulins Historical Sales by Type (2018-2024)
4.1.2 Global Human Hyperimmune Globulins Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
4.2 Global Human Hyperimmune Globulins Revenue by Type
4.2.1 Global Human Hyperimmune Globulins Historical Revenue by Type (2018-2024)
4.2.2 Global Human Hyperimmune Globulins Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
4.3 Global Human Hyperimmune Globulins Price by Type
4.3.1 Global Human Hyperimmune Globulins Price by Type (2018-2024)
4.3.2 Global Human Hyperimmune Globulins Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Hyperimmune Globulins Sales by Application
5.1.1 Global Human Hyperimmune Globulins Historical Sales by Application (2018-2024)
5.1.2 Global Human Hyperimmune Globulins Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
5.2 Global Human Hyperimmune Globulins Revenue by Application
5.2.1 Global Human Hyperimmune Globulins Historical Revenue by Application (2018-2024)
5.2.2 Global Human Hyperimmune Globulins Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
5.3 Global Human Hyperimmune Globulins Price by Application
5.3.1 Global Human Hyperimmune Globulins Price by Application (2018-2024)
5.3.2 Global Human Hyperimmune Globulins Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Hyperimmune Globulins Market Size by Type
6.1.1 US & Canada Human Hyperimmune Globulins Sales by Type (2018-2029)
6.1.2 US & Canada Human Hyperimmune Globulins Revenue by Type (2018-2029)
6.2 US & Canada Human Hyperimmune Globulins Market Size by Application
6.2.1 US & Canada Human Hyperimmune Globulins Sales by Application (2018-2029)
6.2.2 US & Canada Human Hyperimmune Globulins Revenue by Application (2018-2029)
6.3 US & Canada Human Hyperimmune Globulins Market Size by Country
6.3.1 US & Canada Human Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Hyperimmune Globulins Sales by Country (2018-2029)
6.3.3 US & Canada Human Hyperimmune Globulins Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Hyperimmune Globulins Market Size by Type
7.1.1 Europe Human Hyperimmune Globulins Sales by Type (2018-2029)
7.1.2 Europe Human Hyperimmune Globulins Revenue by Type (2018-2029)
7.2 Europe Human Hyperimmune Globulins Market Size by Application
7.2.1 Europe Human Hyperimmune Globulins Sales by Application (2018-2029)
7.2.2 Europe Human Hyperimmune Globulins Revenue by Application (2018-2029)
7.3 Europe Human Hyperimmune Globulins Market Size by Country
7.3.1 Europe Human Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Hyperimmune Globulins Sales by Country (2018-2029)
7.3.3 Europe Human Hyperimmune Globulins Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Hyperimmune Globulins Market Size
8.1.1 China Human Hyperimmune Globulins Sales (2018-2029)
8.1.2 China Human Hyperimmune Globulins Revenue (2018-2029)
8.2 China Human Hyperimmune Globulins Market Size by Application
8.2.1 China Human Hyperimmune Globulins Sales by Application (2018-2029)
8.2.2 China Human Hyperimmune Globulins Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Hyperimmune Globulins Market Size by Type
9.1.1 Asia Human Hyperimmune Globulins Sales by Type (2018-2029)
9.1.2 Asia Human Hyperimmune Globulins Revenue by Type (2018-2029)
9.2 Asia Human Hyperimmune Globulins Market Size by Application
9.2.1 Asia Human Hyperimmune Globulins Sales by Application (2018-2029)
9.2.2 Asia Human Hyperimmune Globulins Revenue by Application (2018-2029)
9.3 Asia Human Hyperimmune Globulins Sales by Region
9.3.1 Asia Human Hyperimmune Globulins Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Hyperimmune Globulins Revenue by Region (2018-2029)
9.3.3 Asia Human Hyperimmune Globulins Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Hyperimmune Globulins Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Hyperimmune Globulins Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Country
10.3.1 Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Information
11.1.2 CSL Behring Overview
11.1.3 CSL Behring Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 CSL Behring Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSL Behring Recent Developments
11.2 Grifols
11.2.1 Grifols Company Information
11.2.2 Grifols Overview
11.2.3 Grifols Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Grifols Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Grifols Recent Developments
11.3 Biotest
11.3.1 Biotest Company Information
11.3.2 Biotest Overview
11.3.3 Biotest Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Biotest Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Biotest Recent Developments
11.4 Kedrion
11.4.1 Kedrion Company Information
11.4.2 Kedrion Overview
11.4.3 Kedrion Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Kedrion Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion Recent Developments
11.5 CBPO
11.5.1 CBPO Company Information
11.5.2 CBPO Overview
11.5.3 CBPO Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 CBPO Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CBPO Recent Developments
11.6 Emergent (Cangene)
11.6.1 Emergent (Cangene) Company Information
11.6.2 Emergent (Cangene) Overview
11.6.3 Emergent (Cangene) Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Emergent (Cangene) Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Emergent (Cangene) Recent Developments
11.7 Kamada
11.7.1 Kamada Company Information
11.7.2 Kamada Overview
11.7.3 Kamada Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Kamada Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kamada Recent Developments
11.8 CNBG
11.8.1 CNBG Company Information
11.8.2 CNBG Overview
11.8.3 CNBG Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 CNBG Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 CNBG Recent Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Company Information
11.9.2 Hualan Bio Overview
11.9.3 Hualan Bio Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Hualan Bio Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Bio Recent Developments
11.10 Shanghai RAAS
11.10.1 Shanghai RAAS Company Information
11.10.2 Shanghai RAAS Overview
11.10.3 Shanghai RAAS Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Shanghai RAAS Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanghai RAAS Recent Developments
11.11 Sichuan Yuanda Shuyang
11.11.1 Sichuan Yuanda Shuyang Company Information
11.11.2 Sichuan Yuanda Shuyang Overview
11.11.3 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sichuan Yuanda Shuyang Recent Developments
11.12 ADMA Biologics
11.12.1 ADMA Biologics Company Information
11.12.2 ADMA Biologics Overview
11.12.3 ADMA Biologics Human Hyperimmune Globulins Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 ADMA Biologics Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 ADMA Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Hyperimmune Globulins Industry Chain Analysis
12.2 Human Hyperimmune Globulins Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Hyperimmune Globulins Production Mode & Process
12.4 Human Hyperimmune Globulins Sales and Marketing
12.4.1 Human Hyperimmune Globulins Sales Channels
12.4.2 Human Hyperimmune Globulins Distributors
12.5 Human Hyperimmune Globulins Customers
13 Market Dynamics
13.1 Human Hyperimmune Globulins Industry Trends
13.2 Human Hyperimmune Globulins Market Drivers
13.3 Human Hyperimmune Globulins Market Challenges
13.4 Human Hyperimmune Globulins Market Restraints
14 Key Findings in The Global Human Hyperimmune Globulins Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Hepatitis B Immunoglobulins
Table 3. Major Manufacturers of Rabies Immunoglobulins
Table 4. Major Manufacturers of Tetanus Immunoglobulins
Table 5. Major Manufacturers of Others
Table 6. Global Human Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Human Hyperimmune Globulins Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Hyperimmune Globulins Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Human Hyperimmune Globulins Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Human Hyperimmune Globulins Revenue Market Share by Region (2018-2024)
Table 11. Global Human Hyperimmune Globulins Revenue Market Share by Region (2024-2029)
Table 12. Global Human Hyperimmune Globulins Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Human Hyperimmune Globulins Sales by Region (2018-2024) & (K Units)
Table 14. Global Human Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)
Table 15. Global Human Hyperimmune Globulins Sales Market Share by Region (2018-2024)
Table 16. Global Human Hyperimmune Globulins Sales Market Share by Region (2024-2029)
Table 17. Global Human Hyperimmune Globulins Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Human Hyperimmune Globulins Sales Share by Manufacturers (2018-2024)
Table 19. Global Human Hyperimmune Globulins Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Human Hyperimmune Globulins Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Human Hyperimmune Globulins, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Human Hyperimmune Globulins Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Human Hyperimmune Globulins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Human Hyperimmune Globulins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Hyperimmune Globulins as of 2022)
Table 25. Global Key Manufacturers of Human Hyperimmune Globulins, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Human Hyperimmune Globulins, Product Offered and Application
Table 27. Global Key Manufacturers of Human Hyperimmune Globulins, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 30. Global Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 31. Global Human Hyperimmune Globulins Sales Share by Type (2018-2024)
Table 32. Global Human Hyperimmune Globulins Sales Share by Type (2024-2029)
Table 33. Global Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Human Hyperimmune Globulins Revenue Share by Type (2018-2024)
Table 36. Global Human Hyperimmune Globulins Revenue Share by Type (2024-2029)
Table 37. Human Hyperimmune Globulins Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Human Hyperimmune Globulins Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 40. Global Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 41. Global Human Hyperimmune Globulins Sales Share by Application (2018-2024)
Table 42. Global Human Hyperimmune Globulins Sales Share by Application (2024-2029)
Table 43. Global Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Human Hyperimmune Globulins Revenue Share by Application (2018-2024)
Table 46. Global Human Hyperimmune Globulins Revenue Share by Application (2024-2029)
Table 47. Human Hyperimmune Globulins Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Human Hyperimmune Globulins Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Human Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Human Hyperimmune Globulins Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Human Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 62. Europe Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 63. Europe Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 64. Europe Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 67. Europe Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 68. Europe Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Human Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Human Hyperimmune Globulins Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Human Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 74. Europe Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 75. China Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 76. China Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 77. China Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 80. China Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 81. China Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 84. Asia Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 85. Asia Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 88. Asia Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 89. Asia Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Human Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Human Hyperimmune Globulins Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Human Hyperimmune Globulins Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Human Hyperimmune Globulins Sales by Region (2018-2024) & (K Units)
Table 95. Asia Human Hyperimmune Globulins Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales by Country (2024-2029) & (K Units)
Table 109. CSL Behring Company Information
Table 110. CSL Behring Description and Major Businesses
Table 111. CSL Behring Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. CSL Behring Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. CSL Behring Recent Developments
Table 114. Grifols Company Information
Table 115. Grifols Description and Major Businesses
Table 116. Grifols Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Grifols Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Grifols Recent Developments
Table 119. Biotest Company Information
Table 120. Biotest Description and Major Businesses
Table 121. Biotest Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Biotest Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Biotest Recent Developments
Table 124. Kedrion Company Information
Table 125. Kedrion Description and Major Businesses
Table 126. Kedrion Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Kedrion Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Kedrion Recent Developments
Table 129. CBPO Company Information
Table 130. CBPO Description and Major Businesses
Table 131. CBPO Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. CBPO Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. CBPO Recent Developments
Table 134. Emergent (Cangene) Company Information
Table 135. Emergent (Cangene) Description and Major Businesses
Table 136. Emergent (Cangene) Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Emergent (Cangene) Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Emergent (Cangene) Recent Developments
Table 139. Kamada Company Information
Table 140. Kamada Description and Major Businesses
Table 141. Kamada Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Kamada Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Kamada Recent Developments
Table 144. CNBG Company Information
Table 145. CNBG Description and Major Businesses
Table 146. CNBG Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. CNBG Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. CNBG Recent Developments
Table 149. Hualan Bio Company Information
Table 150. Hualan Bio Description and Major Businesses
Table 151. Hualan Bio Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Hualan Bio Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Hualan Bio Recent Developments
Table 154. Shanghai RAAS Company Information
Table 155. Shanghai RAAS Description and Major Businesses
Table 156. Shanghai RAAS Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Shanghai RAAS Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Shanghai RAAS Recent Developments
Table 159. Sichuan Yuanda Shuyang Company Information
Table 160. Sichuan Yuanda Shuyang Description and Major Businesses
Table 161. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Sichuan Yuanda Shuyang Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Sichuan Yuanda Shuyang Recent Developments
Table 164. ADMA Biologics Company Information
Table 165. ADMA Biologics Description and Major Businesses
Table 166. ADMA Biologics Human Hyperimmune Globulins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. ADMA Biologics Human Hyperimmune Globulins Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. ADMA Biologics Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Human Hyperimmune Globulins Distributors List
Table 172. Human Hyperimmune Globulins Customers List
Table 173. Human Hyperimmune Globulins Market Trends
Table 174. Human Hyperimmune Globulins Market Drivers
Table 175. Human Hyperimmune Globulins Market Challenges
Table 176. Human Hyperimmune Globulins Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hyperimmune Globulins Product Picture
Figure 2. Global Human Hyperimmune Globulins Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Hyperimmune Globulins Market Share by Type in 2022 & 2029
Figure 4. Hepatitis B Immunoglobulins Product Picture
Figure 5. Rabies Immunoglobulins Product Picture
Figure 6. Tetanus Immunoglobulins Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Hyperimmune Globulins Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Human Hyperimmune Globulins Market Share by Application in 2022 & 2029
Figure 10. Government Institutions
Figure 11. Private Sector
Figure 12. Others
Figure 13. Human Hyperimmune Globulins Report Years Considered
Figure 14. Global Human Hyperimmune Globulins Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Hyperimmune Globulins Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Hyperimmune Globulins Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Hyperimmune Globulins Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Hyperimmune Globulins Sales 2018-2029 ((K Units)
Figure 19. Global Human Hyperimmune Globulins Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Hyperimmune Globulins Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Hyperimmune Globulins in the World: Market Share by Human Hyperimmune Globulins Revenue in 2022
Figure 32. Global Human Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 34. Global Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 36. Global Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Hyperimmune Globulins Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Hyperimmune Globulins Sales Share by Country (2018-2029)
Figure 43. U.S. Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Hyperimmune Globulins Revenue Share by Country (2018-2029)
Figure 50. Europe Human Hyperimmune Globulins Sales Share by Country (2018-2029)
Figure 51. Germany Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 57. China Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 58. China Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 59. China Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Hyperimmune Globulins Revenue Share by Region (2018-2029)
Figure 65. Asia Human Hyperimmune Globulins Sales Share by Region (2018-2029)
Figure 66. Japan Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Hyperimmune Globulins Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Hyperimmune Globulins Sales Share by Country (2018-2029)
Figure 77. Brazil Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Hyperimmune Globulins Revenue (2018-2029) & (US$ Million)
Figure 82. Human Hyperimmune Globulins Value Chain
Figure 83. Human Hyperimmune Globulins Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries